Research Article
Characteristic of Clinical Studies on Baduanjin during 2000–2019: A Comprehensive Review
Table 2
Clinical trials of Baduanjin organized by prevalence of disease categories based on ICD-11 classifications.
| Chapter | Blocks | Disease/conditions (ICD-11 codes) | No. of study |
| 15 | FA00–FC0Z | Diseases of the musculoskeletal system or connective tissue | 124 | 05 | 5A00–5D46 | Endocrine, nutritional, or metabolic diseases | 124 | 11 | BA00–BE2Z | Diseases of the circulatory system | 114 | 08 | 8A00–8E7Z | Diseases of the nervous system | 65 | 12 | CA00–CB7Z | Diseases of the respiratory system | 63 | 06 | 6A00–6E8Z | Mental, behavioral, or neurodevelopmental disorders | 46 | 02 | 2A00–2F9Z | Neoplasms | 32 | 16 | GA00–GC8Z | Diseases of the genitourinary system | 24 | 07 | 7A00–7B2Z | Sleep-wake disorders | 17 | 13 | DA00–DE2Z | Diseases of the digestive system | 10 | 14 | EA00–EM0Z | Diseases of the skin | 6 | 04 | 4A00–4B4Z | Diseases of the immune system | 5 | 01 | 1A00–1H0Z | Certain infectious or parasitic diseases | 4 | 09 | 9A00–9E1Z | Diseases of the visual system | 2 |
|
|
ICD-11, International Classification of Diseases, 11th Revision. Some systematic reviews involved more than one type of diseases or conditions. |